Heidelberg
Universität Heidelberg
Targeting tumor-associated macrophages in the immune-microenvironment of meningiomas
Use of biopsy-derived tumor organoids for personalized drug testing in recurrent glioblastoma
Automated drug screening in ependymoma organoids identifies HDAC, anthracyclines, and proteasome inhibitors as potential therapeutic candidates
Quantification of diverse immune cell subsets in primary meningiomas
Combinatorial drug screening identifies carfilzomib and enzalutamide for the treatment of aggressive meningiomas
The pharmacological atlas of meningiomas
Targeting tumor-associated macrophages in the immune-microenvironment of meningiomas
Prospective longitudinal assessment of health-related quality of life and psycho-oncological burden in meningioma patients after tumor resection
Central nervous solitary fibrous tumors: A case series of 49 patients
Use of biopsy-derived tumor organoids for personalized drug testing in recurrent glioblastoma
Stereotactic Laser Interstitial Thermal Therapy (LITT) and preclinical tumororganoid-based drug screening in recurrent high-grade glioma. First experiences from the Hi-SMILE study